Suppr超能文献

神经发育和疾病中的腺苷到肌苷 RNA 编辑。

Adenosine-to-inosine RNA editing in neurological development and disease.

机构信息

Research Institute for Biomedical Sciences, Tokyo University of Science, Noda-shi, Chiba, Japan.

出版信息

RNA Biol. 2021 Jul;18(7):999-1013. doi: 10.1080/15476286.2020.1867797. Epub 2021 Jan 6.

Abstract

Adenosine-to-inosine (A-to-I) editing is one of the most prevalent post-transcriptional RNA modifications in metazoan. This reaction is catalysed by enzymes called adenosine deaminases acting on RNA (ADARs). RNA editing is involved in the regulation of protein function and gene expression. The numerous A-to-I editing sites have been identified in both coding and non-coding RNA transcripts. These editing sites are also found in various genes expressed in the central nervous system (CNS) and play an important role in neurological development and brain function. Aberrant regulation of RNA editing has been associated with the pathogenesis of neurological and psychiatric disorders, suggesting the physiological significance of RNA editing in the CNS. In this review, we discuss the current knowledge of editing on neurological disease and development.

摘要

腺苷到肌苷(A-to-I)编辑是后生动物中最普遍的转录后 RNA 修饰之一。该反应由称为 RNA 作用腺嘌呤脱氨酶(ADARs)的酶催化。RNA 编辑参与蛋白质功能和基因表达的调节。在编码和非编码 RNA 转录本中都发现了许多 A-to-I 编辑位点。这些编辑位点也存在于中枢神经系统(CNS)中表达的各种基因中,在神经发育和大脑功能中发挥重要作用。RNA 编辑的异常调节与神经和精神疾病的发病机制有关,表明 RNA 编辑在中枢神经系统中的生理意义。在这篇综述中,我们讨论了编辑在神经疾病和发育中的最新知识。

相似文献

1
Adenosine-to-inosine RNA editing in neurological development and disease.
RNA Biol. 2021 Jul;18(7):999-1013. doi: 10.1080/15476286.2020.1867797. Epub 2021 Jan 6.
2
RNA Editing in Neurological and Neurodegenerative Disorders.
Methods Mol Biol. 2021;2181:309-330. doi: 10.1007/978-1-0716-0787-9_18.
3
RNA editing by mammalian ADARs.
Adv Genet. 2011;73:87-120. doi: 10.1016/B978-0-12-380860-8.00003-3.
4
5
Editing inducer elements increases A-to-I editing efficiency in the mammalian transcriptome.
Genome Biol. 2017 Oct 23;18(1):195. doi: 10.1186/s13059-017-1324-x.
6
Editing of AMPA and serotonin 2C receptors in individual central neurons, controlling wakefulness.
Cell Mol Neurobiol. 2007 Aug;27(5):669-80. doi: 10.1007/s10571-007-9153-1.
7
RNA editing and alternative splicing of human serotonin 2C receptor in schizophrenia.
J Neurochem. 2003 Dec;87(6):1402-12. doi: 10.1046/j.1471-4159.2003.02115.x.
8
Adenosine-to-Inosine RNA Editing Enzyme ADAR and microRNAs.
Methods Mol Biol. 2021;2181:83-95. doi: 10.1007/978-1-0716-0787-9_6.
9
[Inefficient A-to-I RNA editing and ALS].
Rinsho Shinkeigaku. 2010 Nov;50(11):978. doi: 10.5692/clinicalneurol.50.978.

引用本文的文献

1
Exosome-Based Therapeutics: A Natural Solution to Overcoming the Blood-Brain Barrier in Neurodegenerative Diseases.
MedComm (2020). 2025 Sep 12;6(9):e70386. doi: 10.1002/mco2.70386. eCollection 2025 Sep.
2
Uncovering the Epitranscriptome: A Review on mRNA Modifications and Emerging Frontiers.
Genes (Basel). 2025 Aug 12;16(8):951. doi: 10.3390/genes16080951.
3
Deciphering the mechanistic roles of ADARs in cancer pathogenesis, tumor immune evasion, and drug resistance.
Front Immunol. 2025 Aug 7;16:1621585. doi: 10.3389/fimmu.2025.1621585. eCollection 2025.
5
6
Exosomes as nanocarriers for brain-targeted delivery of therapeutic nucleic acids: advances and challenges.
J Nanobiotechnology. 2025 Jun 18;23(1):453. doi: 10.1186/s12951-025-03528-2.
7
Landscape of A-I RNA editing in mouse, pig, macaque, and human brains.
Nucleic Acids Res. 2025 Jun 6;53(11). doi: 10.1093/nar/gkaf534.
8
m6A methylation: a new frontier in epilepsy research and therapeutics.
EXCLI J. 2025 May 30;24:578-611. doi: 10.17179/2025-8359. eCollection 2025.
9
RNA modifications and their role in gene expression.
Front Mol Biosci. 2025 Apr 25;12:1537861. doi: 10.3389/fmolb.2025.1537861. eCollection 2025.
10
Advances in Detection Methods for A-to-I RNA Editing.
Wiley Interdiscip Rev RNA. 2025 Mar-Apr;16(2):e70014. doi: 10.1002/wrna.70014.

本文引用的文献

1
Biallelic variants in , encoding a dsRNA-specific adenosine deaminase, cause a severe developmental and epileptic encephalopathy.
J Med Genet. 2021 Jul;58(7):495-504. doi: 10.1136/jmedgenet-2020-107048. Epub 2020 Jul 27.
2
Bi-allelic ADARB1 Variants Associated with Microcephaly, Intellectual Disability, and Seizures.
Am J Hum Genet. 2020 Apr 2;106(4):467-483. doi: 10.1016/j.ajhg.2020.02.015. Epub 2020 Mar 26.
3
The majority of A-to-I RNA editing is not required for mammalian homeostasis.
Genome Biol. 2019 Dec 9;20(1):268. doi: 10.1186/s13059-019-1873-2.
4
RNA binding candidates for human ADAR3 from substrates of a gain of function mutant expressed in neuronal cells.
Nucleic Acids Res. 2019 Nov 18;47(20):10801-10814. doi: 10.1093/nar/gkz815.
5
AMPA receptor GluA2 subunit defects are a cause of neurodevelopmental disorders.
Nat Commun. 2019 Jul 12;10(1):3094. doi: 10.1038/s41467-019-10910-w.
6
Pathophysiology and Diagnosis of ALS: Insights from Advances in Neurophysiological Techniques.
Int J Mol Sci. 2019 Jun 10;20(11):2818. doi: 10.3390/ijms20112818.
7
The epitranscriptome and synaptic plasticity.
Curr Opin Neurobiol. 2019 Dec;59:41-48. doi: 10.1016/j.conb.2019.04.007. Epub 2019 May 17.
8
Dyschromatosis symmetrica hereditaria and reticulate acropigmentation of Kitamura: An update.
J Dermatol Sci. 2019 Feb;93(2):75-81. doi: 10.1016/j.jdermsci.2019.01.004. Epub 2019 Jan 15.
9
Regulation of RNA editing by RNA-binding proteins in human cells.
Commun Biol. 2019 Jan 14;2:19. doi: 10.1038/s42003-018-0271-8. eCollection 2019.
10
Current strategies for Site-Directed RNA Editing using ADARs.
Methods. 2019 Mar 1;156:16-24. doi: 10.1016/j.ymeth.2018.11.016. Epub 2018 Nov 29.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验